Lyimo, Eric
Fougeroux, Cyrielle
Malabeja, Anangisye
Mbwana, Joyce
Hayuma, Paul M.
Liheluka, Edwin
Turner, Louise
Gesase, Samwel
Lavstsen, Thomas
Lusingu, John P. A.
Minja, Daniel T. R.
Wang, Christian W.
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TMA2015SF–998-MaReCa)
Article History
Received: 2 June 2022
Accepted: 29 October 2022
First Online: 12 November 2022
Declarations
:
: This study received ethical approval from Tanzania's Medical Research Coordinating Committee (MRCC). Informed consent and/or assent was obtained from all subjects and/or their legal guardian(s). During the survey the Swahili language was used to convey oral and written information about the study objectives, procedures, confidentiality, and voluntary participation. Prior to the signing of the informed consent or assent forms, participants were given an opportunity to query any of the study’s objectives or procedures. Witnesses assisted with the informed consent or assent for study participants who were unable to read or write. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.